iShares Biotechnology ETF $IBB Shares Acquired by Barclays PLC

Barclays PLC lifted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 6.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 416,191 shares of the financial services provider’s stock after buying an additional 26,032 shares during the quarter. Barclays PLC owned 0.97% of iShares Biotechnology ETF worth $60,085,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth $25,000. Financial Gravity Companies Inc. acquired a new position in iShares Biotechnology ETF during the second quarter worth about $29,000. Ashton Thomas Securities LLC purchased a new position in iShares Biotechnology ETF in the third quarter valued at about $36,000. Bronte Capital Management Pty Ltd. lifted its position in shares of iShares Biotechnology ETF by 12.6% during the 2nd quarter. Bronte Capital Management Pty Ltd. now owns 295,346 shares of the financial services provider’s stock valued at $37,000 after acquiring an additional 32,947 shares during the period. Finally, Parkside Financial Bank & Trust increased its stake in iShares Biotechnology ETF by 48.6% in the 3rd quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock valued at $38,000 after purchasing an additional 87 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 2.2%

IBB opened at $171.29 on Tuesday. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $179.64. The business’s fifty day moving average is $172.69 and its two-hundred day moving average is $161.86.

iShares Biotechnology ETF Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Tuesday, December 16th were issued a $0.1831 dividend. This represents a $0.73 annualized dividend and a dividend yield of 0.4%. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. The ex-dividend date of this dividend was Tuesday, December 16th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.